This inventor holds 2 USPTO granted patents. Top assignee: Knoll Aktiengesellschaft. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovations of Andrew Philip Crew
Introduction
Andrew Philip Crew is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on isoquinoline derivatives. With a total of 2 patents to his name, Crew's inventions reflect his dedication to advancing medical science.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Isoquinoline derivatives as therapeutic agents." This patent focuses on tetrahydroisoquinoline compounds of formula I and their pharmaceutically acceptable salts. The compounds feature various substituents, including H, halo, hydroxy, and alkyl groups, which enhance their therapeutic potential.
Career Highlights
Andrew Crew is currently associated with Knoll Aktiengesellschaft, a company known for its commitment to pharmaceutical innovation. His work at Knoll has allowed him to explore new avenues in drug development, contributing to the advancement of therapeutic solutions.
Collaborations
Throughout his career, Crew has collaborated with esteemed colleagues such as Bruce Jeremy Sargent and David N Johnston. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Andrew Philip Crew's contributions to the field of therapeutic agents exemplify the impact of innovative thinking in medicine. His patents and collaborations highlight the importance of teamwork in driving advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile